Ishida H, Kawai T, Tanabe K, Hayasaka Y, Yasuo M, Toma H, Ota K
Department of Surgery III, Tokyo Women's Medical College, Japan.
Transplantation. 1996 Jul 15;62(1):126-8. doi: 10.1097/00007890-199607150-00024.
To study the relevance of microchimerism to the long-term outcome of renal allografting, we analyzed the frequency of microchimerism in kidney transplant recipients who had stable graft function for 15 years or longer. Among the 104 recipients who underwent kidney transplantation between 1971 and 1980, 27 renal allografts (26%) are still functioning. Among these 27 patients, 13 recipients whose donor was still alive and cooperative were investigated for the presence of microchimerism in the peripheral blood and for their immunological status. Microchimerism was tested using the polymerase chain reaction (PCR)-single-strand conformation polymorphism (SSCP) method. To test the sensitivity of PCP-SSCP, the peripheral blood obtained within 5 weeks after transplantation (four kidney transplants, three liver transplants) was also examined. Microchimerism was detectable in five patients within 5 weeks of transplantation (kidney transplantation, 3/4; liver transplantation 2/3. However, in the patients studied 15 years after transplantation, microchimerism was detected in only one recipient (1/13). In this chimeric patient, mixed lymphocyte response revealed high responsiveness against donor antigen. In contrast, some patients who did not have chimerism showed donor-specific hyporesponsiveness in mixed lymphocyte response assay and did not develop antidonor antibody, according to flow cytometric analysis. Microchimerism is an infrequent state in the long-term survivors of kidney allografting, and this state is irrelevant to donor-specific unresponsiveness.
为研究微嵌合体与肾移植长期预后的相关性,我们分析了移植肾功能稳定达15年及以上的肾移植受者体内微嵌合体的频率。在1971年至1980年间接受肾移植的104例受者中,27例(26%)肾移植仍在发挥功能。在这27例患者中,对13例供者仍存活且配合的受者进行了外周血微嵌合体检测及免疫状态检查。采用聚合酶链反应(PCR)-单链构象多态性(SSCP)方法检测微嵌合体。为检测PCR-SSCP的敏感性,还对移植后5周内采集的外周血(4例肾移植、3例肝移植)进行了检查。移植后5周内,5例患者检测到微嵌合体(肾移植,3/4;肝移植,2/3)。然而,在移植后15年进行研究的患者中,仅1例受者(1/13)检测到微嵌合体。在这名嵌合患者中,混合淋巴细胞反应显示对供者抗原具有高反应性。相反,根据流式细胞术分析,一些未出现嵌合体的患者在混合淋巴细胞反应试验中表现出对供者特异性低反应性,且未产生抗供者抗体。微嵌合体在肾移植长期存活者中是一种罕见状态,且这种状态与供者特异性无反应性无关。